Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


08.04.2019

1 Acta Neuropathol
1 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Brain
1 Brain Res
1 Exp Neurol
3 J Alzheimers Dis
1 J Neurol
1 J Neurosci
1 JAMA
1 Lancet Neurol
1 Nat Neurosci
1 Neurobiol Aging
2 Neurobiol Dis
1 Neurochem Res
1 Neurology
1 Neuropsychology
1 Neurosci Lett
1 Neuroscience
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. ESTUS S, Shaw BC, Devanney N, Katsumata Y, et al
    Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Acta Neuropathol. 2019 Apr 4. pii: 10.1007/s00401-019-02000.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. BIHLMEYER NA, Merrill E, Lambert Y, Srivastava GP, et al
    Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 29. pii: S1552-5260(19)30032.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  3. BAILLON S, Gasper A, Wilson-Morkeh F, Pritchard M, et al
    Prevalence and Severity of Neuropsychiatric Symptoms in Early- Versus Late-Onset Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2019 Apr 1:1533317519841191.
    PubMed     Text format     Abstract available


    Brain

  4. LYON L
    Is an epidemic of sleeplessness increasing the incidence of Alzheimer's disease?
    Brain. 2019 Apr 1. pii: 5425265. doi: 10.1093.
    PubMed     Text format    


    Brain Res

  5. GALLINO D, Devenyi GA, Germann J, Guma E, et al
    Longitudinal assessment of the neuroanatomical consequences of deep brain stimulation: Application of fornical DBS in an Alzheimer's mouse model.
    Brain Res. 2019 Mar 26. pii: S0006-8993(19)30169.
    PubMed     Text format    


    Exp Neurol

  6. DE SILVA NML, Goncalves RA, Boehnke SE, Forny-Germano L, et al
    Understanding the link between insulin resistance and Alzheimer's disease: Insights from animal models.
    Exp Neurol. 2019 Mar 28. pii: S0014-4886(18)30704.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  7. OLIVER DMA, Reddy PH
    Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD190048. doi: 10.3233/JAD-190048.
    PubMed     Text format     Abstract available

  8. WATT AD, Jenkins NL, McColl G, Collins S, et al
    "To Treat or not To Treat": Informing the Decision for Disease-Modifying Therapy in Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD190033. doi: 10.3233/JAD-190033.
    PubMed     Text format     Abstract available

  9. YUAN J, Meloni BP, Shi T, Bonser A, et al
    The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD181249. doi: 10.3233/JAD-181249.
    PubMed     Text format     Abstract available


    J Neurol

  10. SLACHEVSKY A, Forno G, Barraza P, Mioshi E, et al
    Mapping the neuroanatomy of functional decline in Alzheimer's disease from basic to advanced activities of daily living.
    J Neurol. 2019 Apr 4. pii: 10.1007/s00415-019-09260.
    PubMed     Text format     Abstract available


    J Neurosci

  11. FLECK D, Phu L, Verschueren E, Hinkle T, et al
    PTCD1 is required for mitochondrial oxidative-phosphorylation: possible genetic association with Alzheimer's disease.
    J Neurosci. 2019 Apr 4. pii: JNEUROSCI.0116-19.2019.
    PubMed     Text format     Abstract available


    JAMA

  12. HAMPTON T
    Studies Further Support Transmissibility of Alzheimer Disease-Associated Proteins.
    JAMA. 2019;321:1243-1244.
    PubMed     Text format    


    Lancet Neurol

  13. MORGAN J
    No one knows what tomorrow might bring.
    Lancet Neurol. 2018;17:585.
    PubMed     Text format    


    Nat Neurosci

  14. ZHANG P, Kishimoto Y, Grammatikakis I, Gottimukkala K, et al
    Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model.
    Nat Neurosci. 2019 Apr 1. pii: 10.1038/s41593-019-0372.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  15. FONSECA LM, Mattar GP, Haddad GG, Goncalves AS, et al
    Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome.
    Neurobiol Aging. 2019;78:186-194.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  16. TETER B, Morihara T, Lim GP, Chu T, et al
    Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
    Neurobiol Dis. 2019 Apr 2. pii: S0969-9961(19)30045.
    PubMed     Text format     Abstract available

  17. SERGEANT N, Vingtdeux V, Eddarkaoui S, Gay M, et al
    New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease.
    Neurobiol Dis. 2019 Mar 27. pii: S0969-9961(18)30327.
    PubMed     Text format     Abstract available


    Neurochem Res

  18. YADAV E, Singh D, Debnath B, Rathee P, et al
    Molecular Docking and Cognitive Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer's Disease Like Condition.
    Neurochem Res. 2019 Apr 4. pii: 10.1007/s11064-019-02792.
    PubMed     Text format     Abstract available


    Neurology

  19. KANG SW, Jeon S, Yoo HS, Chung SJ, et al
    Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007373.
    PubMed     Text format     Abstract available


    Neuropsychology

  20. VONK JMJ, Flores RJ, Rosado D, Qian C, et al
    Semantic network function captured by word frequency in nondemented APOE epsilon4 carriers.
    Neuropsychology. 2019;33:256-262.
    PubMed     Text format     Abstract available


    Neurosci Lett

  21. CHAKRABORTY S, Lennon JC, Malkaram SA, Zeng Y, et al
    Serotonergic System, Cognition, and BPSD in Alzheimer's disease.
    Neurosci Lett. 2019 Apr 1. pii: S0304-3940(19)30214.
    PubMed     Text format     Abstract available


    Neuroscience

  22. PU D, Zhao Y, Chen J, Sun Y, et al
    Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
    Neuroscience. 2018;381:35-45.
    PubMed     Text format     Abstract available


    PLoS One

  23. NOMOTO S, Kinno R, Ochiai H, Kubota S, et al
    The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2019;14:e0214676.
    PubMed     Text format     Abstract available

  24. ZHANG YS, Zhou N, Knoll BM, Samra S, et al
    Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer's Disease on optical coherence tomography angiography.
    PLoS One. 2019;14:e0214685.
    PubMed     Text format     Abstract available

  25. BALLARINI NM, Rosenkranz GK, Jaki T, Konig F, et al
    Subgroup identification in clinical trials via the predicted individual treatment effect.
    PLoS One. 2018;13:e0205971.
    PubMed     Text format     Abstract available

  26. LIN W, Xie YC, Cheng PY, Dong LY, et al
    Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.
    PLoS One. 2018;13:e0205909.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: